Global footprint Leverage Crystal Pharmatech's tri-region presence (US, Canada, China) and recent facility expansions totaling 120,000 sq ft of R&D and GMP space to offer localized development and manufacturing readiness for multinational clients.

Solid state expert Crystal Pharmatech's focus on solid-state characterization, crystallization, formulation development, and developability assessments positions it as a high-value partner for decisions that reduce risk and accelerate time to clinic.

AI driven analytics Strategic ties with AI-driven drug discovery and advanced structure analysis create cross-sell opportunities for customers seeking integrated, data-backed formulation and stability solutions.

Biologics bridge Affiliations with Crystal Bio Solutions and Crystal NAX extend capabilities into biologics and nucleic acid therapeutics, enabling continuity from small molecules to complex modalities and cross-selling across platforms.

Track record capacity A robust track record of supporting thousands of compounds, global reach, expanding capacities, and industry recognition creates a compelling case for pharma clients seeking scale, reliability, and manufacturing readiness.